Literature DB >> 12727792

Proteomic analysis of a neoplastic mouse lung epithelial cell line whose tumorigenicity has been abrogated by transfection with the gap junction structural gene for connexin 43, Gja1.

Katherine A Peebles1, Mark W Duncan, Randall J Ruch, Alvin M Malkinson.   

Abstract

In order to examine how tumorigenicity is abrogated by gap junctional intercellular communication (GJIC), protein expression was analyzed in four related mouse lung epithelial cell lines that vary in their GJIC status and neoplastic potential. Since alterations in protein expression underlie neoplastic behavior, this proteomic analysis provides insights into the molecular pathogenesis of lung cancer. E10, an immortalized but non-tumorigenic cell line derived from alveolar type II pneumocytes, has functional GJIC. E9, a spontaneous transformant of E10, is GJIC-deficient and is tumorigenic upon injection into a syngeneic mouse. Stable transfection of E9 with Gja1, the gene for the gap junctional protein, connexin 43, re-established GJIC and rendered this line (designated E9-2) non-tumorigenic; the vector transfection control line, E9-41, remains tumorigenic. Proteins extracted from these cell lines were separated by two-dimensional electrophoresis (2DE) and visualized by Coomassie blue staining. We consistently observed differential expression of 27 proteins between E10 and E9 and identified 11 of these by peptide mass mapping. The functions of these proteins include stress response, cytoskeletal structure, signal transduction, apoptosis, immune response, pre-mRNA processing, and carbohydrate metabolism. Gja1 transfection affected the concentrations of four of these proteins, viz. PDI, alpha-enolase, aldolase A, and gelsolin-like protein. PDI concentration was most profoundly affected; E10 cells contain twice as much PDI as E9, and PDI was restored to E10-like levels in the E9-2 transfectant line while remaining at E9-like levels in the vector control E9-41 cells. An association between connexin 43 and PDI expression was also observed in a second set of independently derived type II cell lines. The PDI superfamily has multiple cellular roles including chaperoning assembled glycoproteins, regulating the activities of transcription factors, and regulating disulfide bond formation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12727792     DOI: 10.1093/carcin/bgg008

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  10 in total

1.  Clinical significance of vascular endothelial growth factor and connexin43 for predicting pancreatic cancer clinicopathologic parameters.

Authors:  Qi-Lian Liang; Bi-Rong Wang; Guo-Qiang Chen; Guo-Hong Li; Yan-Yun Xu
Journal:  Med Oncol       Date:  2009-11-12       Impact factor: 3.064

2.  PCBP-1 regulates alternative splicing of the CD44 gene and inhibits invasion in human hepatoma cell line HepG2 cells.

Authors:  Tong Zhang; Xian-Hong Huang; Lan Dong; Deqing Hu; Changhui Ge; Yi-Qun Zhan; Wang-Xiang Xu; Miao Yu; Wei Li; Xiaohui Wang; Liujun Tang; Chang-Yan Li; Xiao-Ming Yang
Journal:  Mol Cancer       Date:  2010-04-02       Impact factor: 27.401

3.  Proteomics analysis identifies molecular targets related to diabetes mellitus-associated bladder dysfunction.

Authors:  Elizabeth Yohannes; Jinsook Chang; George J Christ; Kelvin P Davies; Mark R Chance
Journal:  Mol Cell Proteomics       Date:  2008-03-12       Impact factor: 5.911

4.  Identification of potential lung cancer biomarkers using an in vitro carcinogenesis model.

Authors:  Jung Eun Kim; Kyung Hee Koo; Yeul Hong Kim; Jeongwon Sohn; Yun Gyu Park
Journal:  Exp Mol Med       Date:  2008-12-31       Impact factor: 8.718

5.  Myc promoter-binding protein-1 (MBP-1) is a novel potential prognostic marker in invasive ductal breast carcinoma.

Authors:  Mariavera Lo Presti; Arianna Ferro; Flavia Contino; Claudia Mazzarella; Silvia Sbacchi; Elena Roz; Carmelo Lupo; Giovanni Perconti; Agata Giallongo; Paola Migliorini; Antonio Marrazzo; Salvatore Feo
Journal:  PLoS One       Date:  2010-09-23       Impact factor: 3.240

6.  Overexpression of α-enolase correlates with poor survival in canine mammary carcinoma.

Authors:  Pei-Yi Chu; Nicholas C Hsu; Albert T Liao; Neng-Yao Shih; Ming-Feng Hou; Chen-Hsuan Liu
Journal:  BMC Vet Res       Date:  2011-10-21       Impact factor: 2.741

7.  Expression of Alpha-Enolase (ENO1), Myc Promoter-Binding Protein-1 (MBP-1) and Matrix Metalloproteinases (MMP-2 and MMP-9) Reflect the Nature and Aggressiveness of Breast Tumors.

Authors:  Patrizia Cancemi; Miriam Buttacavoli; Elena Roz; Salvatore Feo
Journal:  Int J Mol Sci       Date:  2019-08-14       Impact factor: 5.923

8.  Generation and characterization of anti-alpha-enolase single-chain antibodies in chicken.

Authors:  Sy-Jye Leu; Yu-Ching Lee; Neng-Yao Shih; I-Jen Huang; Ko-Jiunn Liu; Hsu-Feng Lu; Shih-Yi Huang; Yi-Yuan Yang
Journal:  Vet Immunol Immunopathol       Date:  2010-06-22       Impact factor: 2.046

9.  Proteomic analysis of non-small cell lung cancer tissue interstitial fluids.

Authors:  Shaomin Li; Rui Wang; Mingxin Zhang; Lina Wang; Shaoli Cheng
Journal:  World J Surg Oncol       Date:  2013-08-05       Impact factor: 2.754

10.  Higher incidence of lung adenocarcinomas induced by DMBA in connexin 43 heterozygous knockout mice.

Authors:  Krishna Duro de Oliveira; Marcello Vannucci Tedardi; Bruno Cogliati; Maria Lúcia Zaidan Dagli
Journal:  Biomed Res Int       Date:  2013-10-03       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.